Annual report [Section 13 and 15(d), not S-K Item 405]

Balance Sheet Components

v3.26.1
Balance Sheet Components
 12 Months Ended
Dec. 31, 2025
Balance Sheet Components [Abstract]  
Balance Sheet Components

5. Balance Sheet Components

 

Prepaid expenses and other current assets as of December 31, 2024 and December 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2024     2025  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 263     $ 332  
Prepaid drug manufacturing supply costs     3,604       6,189  
Other     939       1,171  
Total   $ 4,806     $ 7,692  

  

Property and equipment as of December 31, 2024 and December 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2024     2025  
             
Leasehold improvements   $ 49     $ 65  
Lab equipment     26       26  
Furniture and fixtures     39       47  
Subtotal     114       138  
Less accumulated depreciation     (39 )     (72 )
Net   $ 75     $ 66  

Accounts payable as of December 31, 2024 and December 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2024     2025  
             
Trade accounts payable   $ 966     $ 301  
Credit card liability     92       82  
Total   $ 1,058     $ 383  

  

Accrued liabilities as of December 31, 2024 and December 31, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     December 31,  
    2024     2025  
             
Accrued labor costs   $ 1,910     $ 329  
Accrued drug development costs     1,258       753  
Other     394       441  
Total   $ 3,562     $ 1,523